Showing results (41-50 of 113) with videos related to
Sort By:
Pageof 12
The Journal of Pathology. Clinical Research|April 22, 2025
AXL and SRC in clear cell renal cell carcinoma: absence of mutations, rare alternative splicing events, but association of protein expression with poor prognosisMuriel D Brada, Tülay Karakulak, Peter Schraml, et al.Plos One|August 19, 2016
Discretization of Gene Expression Data Unmasks Molecular Subgroups Recurring in Different Human Cancer TypesManfred Beleut, Robert Soeldner, Mark Egorov, et al.Plos One|March 19, 2013
Comparison of EndoPredict and Oncotype DX test results in hormone receptor positive invasive breast cancerZsuzsanna Varga, Peter Sinn, Florian Fritzsche, et al.The Journal of Pathology|January 17, 2002
VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinomaPeter Schraml, Kirsten Struckmann, Florian Hatz, et al.Neoplasia (New York, N.Y.)|December 17, 2013
Identification of molecular tumor markers in renal cell carcinomas with TFE3 protein expression by RNA sequencingDorothee Pflueger, Andrea Sboner, Martina Storz, et al.Human Pathology|September 25, 2007
Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancerKirsten D Mertz, Francesca Demichelis, Robert Kim, et al.Cancer Genomics & Proteomics|January 3, 2012
KRAS mutation is associated with elevated myeloblastin activity in human lung adenocarcinomaThomas Wiedl, Stéphane Collaud, Sven Hillinger, et al.International Journal of Cancer|September 24, 2004
Different types of microsatellite instability in ovarian carcinomaGad Singer, Thore Kallinowski, Arndt Hartmann, et al.Cancers|May 5, 2021
Spatial Distribution of Private Gene Mutations in Clear Cell Renal Cell CarcinomaAriane L Moore, Aashil A Batavia, Jack Kuipers, et al.Oncogene|May 4, 2004
E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancerMartin Oeggerli, Sanja Tomovska, Peter Schraml, et al.Pageof 12